<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Animal Models of Serotonergic Psychedelics</title>
			</titleStmt>
			<publicationStmt>
				<publisher>American Chemical Society (ACS)</publisher>
				<availability status="unknown"><p>Copyright American Chemical Society (ACS)</p>
				</availability>
				<date type="published" when="2012-09-24">September 24, 2012</date>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">James</forename><forename type="middle">B</forename><surname>Hanks</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Departments of Psychiatry and ‡ Neurology</orgName>
								<orgName type="department" key="dep2">Mount Sinai School of Medicine</orgName>
								<orgName type="institution">§ Friedman Brain Institute</orgName>
								<address>
									<postCode>10029</postCode>
									<settlement>New York</settlement>
									<region>New York</region>
									<country key="US">United States</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Javier</forename><surname>González-Maeso</surname></persName>
						</author>
						<title level="a" type="main">Animal Models of Serotonergic Psychedelics</title>
					</analytic>
					<monogr>
						<title level="j" type="main">ACS Chemical Neuroscience</title>
						<title level="j" type="abbrev">ACS Chem. Neurosci.</title>
						<idno type="ISSN">1948-7193</idno>
						<imprint>
							<publisher>American Chemical Society (ACS)</publisher>
							<biblScope unit="volume">4</biblScope>
							<biblScope unit="issue">1</biblScope>
							<biblScope unit="page" from="33" to="42"/>
							<date type="published" when="2012-09-24">September 24, 2012</date>
						</imprint>
					</monogr>
					<idno type="MD5">0B2C136F09884618BD5D857D98A4C704</idno>
					<idno type="DOI">10.1021/cn300138m</idno>
					<note type="submission">Received: August 24, 2012 Accepted: September 24, 2012</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.0" ident="GROBID" when="2025-04-21T20:04+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Psychedelic</term>
					<term>hallucinogenic</term>
					<term>schizophrenia</term>
					<term>psychosis</term>
					<term>serotonin 5-HT 2A receptor</term>
					<term>G protein-coupled receptor (GPCR)</term>
					<term>lysergic acid diethylamide (LSD)</term>
					<term>mouse behavior models</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>The serotonin 5-HT 2A receptor is the major target of psychedelic drugs such as lysergic acid diethylamide (LSD), mescaline, and psilocybin.</s><s>Serotonergic psychedelics induce profound effects on cognition, emotion, and sensory processing that often seem uniquely human.</s><s>This raises questions about the validity of animal models of psychedelic drug action.</s><s>Nonetheless, recent findings suggest behavioral abnormalities elicited by psychedelics in rodents that predict such effects in humans.</s></p><p><s>Here we review the behavioral effects induced by psychedelic drugs in rodent models, discuss the translational potential of these findings, and define areas where further research is needed to better understand the molecular mechanisms and neuronal circuits underlying their neuropsychological effects.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>]<ref type="bibr" target="#b2">[3]</ref><ref type="bibr" target="#b3">[4]</ref><ref type="bibr">[5]</ref> The term psychedelic was coined in 1957 by the British psychiatrist Humphry Osmond to describe the effects of psychoactive drugs such as psilocybin, mescaline, and lysergic acid diethylamide (LSD). <ref type="bibr" target="#b5">6</ref></s><s>These drugs belong to a larger group of substances known as hallucinogens, which also includes dissociatives (e.g., ketamine and phencyclidine), and deliriants (e.g., scopolamine and atropine), as well as compounds such as salvinorin A. Psychedelics all behave as agonists or partial agonists at the serotonin 5-HT 2A receptor, whereas dissociatives and deliriants have been identified as noncompetitive NMDA receptor antagonists, and competitive muscarinic receptor antagonists, respectively.</s><s>4]<ref type="bibr" target="#b14">[15]</ref> Research using behavioral and cognitive tasks indicates that different groups of hallucinogens induce overlapping, yet distinct sets of changes in sensory processing.</s><s>7]<ref type="bibr" target="#b17">[18]</ref><ref type="bibr" target="#b18">[19]</ref><ref type="bibr" target="#b19">[20]</ref><ref type="bibr" target="#b20">[21]</ref><ref type="bibr" target="#b21">[22]</ref><ref type="bibr" target="#b22">[23]</ref><ref type="bibr" target="#b23">[24]</ref> In this review, we will discuss the effects of psychedelics in a range of animal behavioral assays, and their utility as preclinical models of the effects of these drugs in humans.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>■ MODELING PSYCHOSIS IN ANIMALS</head><p><s>Modeling in rodents the neuropsychological effects induced by psychedelic drugs remains controversial.</s><s>The above-mentioned psychometric rating scales HRS and 5D-ASC measure aspects of subjective experience such as "oceanic boundlessness", "dread of ego dissolution", and "spiritual experience" that are difficult to evaluate in the absence of verbalization. <ref type="bibr" target="#b12">13,</ref><ref type="bibr" target="#b24">25</ref></s><s>Furthermore, rodent sensory systems differ from those of humans, with relatively poor vision and comparatively well developed olfactory and somatosensory abilities. <ref type="bibr" target="#b25">26</ref></s><s>Given these limitations, one of the priorities in molecular pharmacology research is to determine which behaviors in rodents predict specific types of neuropsychological effects in humans.</s><s>Ideally, suitable rodent models that are analogous to specific behavioral features induced by psychedelic drugs in humans may be used as tools to investigate the anatomy and molecular mechanisms of action underlying such behavioral outcomes.</s><s>However, every rodent behavioral model has certain limitations.</s></p><p><s>Drug-Induced Head-Twitch Behavior.</s><s>Although it lacks face validity, head-twitch behavioral response is useful as a mouse behavioral proxy of human psychedelic action, mostly due to its predictive validity.</s><s>Head-twitch behavior is induced in mice by all psychedelic 5-HT 2A receptor agonists studied, and is not induced by nonpsychedelic 5-HT 2A agonists such as lisuride and ergotamine. <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28</ref></s><s>Head-twitch is distinct from other behavioral responses in rodents, such as head-weaving (slow, side-to-side lateral head movement) and wet-dog shakes (repetitive shaking of the body), which are observed after administration of dissociative drugs and during morphine withdrawal, respectively. <ref type="bibr" target="#b22">23,</ref><ref type="bibr" target="#b28">29</ref></s><s>To our knowledge, the first study reporting that LSD produces abnormal behavior in mice was published in 1955. <ref type="bibr" target="#b29">30</ref></s><s>It was shown that injection of LSD affected locomotor behavior and induced tremor in mice placed on an inclined glass plate.</s><s>In the search of a behavioral response that was more reliable and easier to quantify, Keller and Umbreit reported the head-twitch behavior induced by LSD as a rapid and violent head shaking. <ref type="bibr" target="#b30">31</ref></s><s>Following these initial studies, it was shown that a large dose of the serotonin precursor 5-hydroxytryptophan (5-HTP) induces head-twitch behavior in mice. <ref type="bibr" target="#b31">32</ref></s><s>However, to our knowledge, equivalent doses of 5-HTP have not been tested in healthy volunteers, and therefore, it remains unknown whether 5-HTP is psychedelic in humans.</s><s>4]<ref type="bibr">[35]</ref><ref type="bibr" target="#b35">[36]</ref> Head-twitch behavior is occasionally observed at baseline, but at a much lower frequency than that observed in the presence of psychedelic treatment.</s></p><p><s>]<ref type="bibr" target="#b38">[39]</ref><ref type="bibr" target="#b39">[40]</ref><ref type="bibr" target="#b40">[41]</ref> Although these findings suggested that serotonin receptors were involved in the head-twitch response, it took more than a decade before LSD and other psychedelics were shown to bind with high affinity to the 5-HT 2A receptor in rat cortex, after which the human 5-HT 2A receptor was cloned and expressed heterologously in murine fibroblasts. <ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b42">43</ref></s><s>Pharmacological inactivation of the 5-HT 2A receptor blocks the head-twitch response induced by systemic administration of psychedelics such as 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI), 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM), 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane (DOB), psilocybin, and mescaline <ref type="bibr" target="#b1">2,</ref><ref type="bibr">35,</ref><ref type="bibr" target="#b35">36,</ref><ref type="bibr" target="#b43">[44]</ref><ref type="bibr" target="#b44">[45]</ref><ref type="bibr" target="#b45">[46]</ref> (see also Table <ref type="table" target="#tab_0">1</ref>).</s><s>Consistent with these studies are observations that 5-HT 2A receptor knockout mice do not exhibit head-twitch response to psychedelics (see also Figure <ref type="figure" target="#fig_0">1</ref>). <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b27">28,</ref><ref type="bibr" target="#b46">47</ref></s><s>The dose-dependent  blockage of the effects of psilocybin in humans by the 5-HT 2A receptor antagonist ketanserin further supports the relevance of these findings. <ref type="bibr">5</ref></s><s>It should also be noted that activation of 5-HT 2C receptors attenuates the head-twitch behavior induced by psychedelics. <ref type="bibr" target="#b47">48</ref></s><s>Since the psychedelic drug DOI has a high affinity for the 5-HT 2A receptor, and a lower affinity for the 5-HT 2C receptor, <ref type="bibr" target="#b49">49</ref> together these findings suggest that the 5-HT 2C receptor might be involved in the inverted U-shaped dose-response of DOI on head-twitch behavior. <ref type="bibr" target="#b47">48</ref></s><s>On the other hand, recent findings showed attenuated head-twitch behavior induced by DOI in 5-HT 2C receptor knockout mice, 50 suggesting that 5-HT 2A and 5-HT 2C receptors interact to influence psychosis-like behavior in a complex way that requires further investigation.</s></p><p><s>There are few examples of false positives obtained with headtwitch behavior as rodent model of psychedelic action.</s><s>2]<ref type="bibr" target="#b53">[53]</ref> It has been suggested that CB 1 receptor antagonists induce head-twitch behavior through a mechanism that requires serotonin release and activation of 5-HT 2A receptors. <ref type="bibr" target="#b51">51,</ref><ref type="bibr" target="#b52">52</ref></s><s>An additional report found that the stimulation of [ 35 S]GTPγS binding (an assay to measure receptor-G protein coupling) by the psychedelic drug DOI was decreased in frontal cortex and hippocampal regions of CB 1 receptor knockout mice, suggesting an adaptive change that attenuates 5-HT 2A receptor-dependent signaling. <ref type="bibr" target="#b54">54</ref></s><s>Since the head-twitch behavior induced by psychedelic drugs is either attenuated or induced by CB 1 receptor agonists (e.g., tetrahydrocannabinol, THC) and antagonists, respectively, together these findings point toward a close functional crosstalk between 5-HT 2A and CB 1 receptors. <ref type="bibr" target="#b51">51,</ref><ref type="bibr" target="#b52">52,</ref><ref type="bibr" target="#b55">55</ref></s><s>he head-twitch behavioral response induced by psychedelic 5-HT 2A agonists is decreased in knockout mice for the metabotropic glutamate 2 (mGlu2) receptor. <ref type="bibr" target="#b56">56</ref></s><s>This glutamate receptor has been shown to be expressed in close molecular proximity with the 5-HT 2A receptor in tissue culture and mouse frontal cortex. <ref type="bibr" target="#b57">57,</ref><ref type="bibr" target="#b58">58</ref></s><s>Although activation of the 5-HT 2A receptor in cortical pyramidal neurons is necessary to induce head-twitch by psychedelics, <ref type="bibr" target="#b26">27,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b45">46</ref> these data suggest that other receptors, including CB 1 and mGlu2, are also involved in the modulation of their behavioral effects.</s></p><p><s>As a summary, head-twitch behavior in mouse is predictive of psychedelic potential in humans with a high degree of reliability.</s></p><p><s>Drug Discrimination.</s><s>In the two-lever drug discrimination paradigm, laboratory animals are trained to recognize the internal state (discriminative stimulus) induced by a specific dose of a particular drug (training drug). <ref type="bibr" target="#b18">19</ref></s><s>Discriminative responses between two operant devices (usually levers) are maintained by food reward. <ref type="bibr">35</ref></s><s>During training sessions, if the training drug is administered, lever presses on the drugdesignated lever produce reinforcement (food reward).</s><s>If vehicle is administered, responses on the alternate, vehicledesignated lever produce reinforcement.</s><s>After the training period, the animal is injected with the drug for the test session, and drug-appropriate responding is presumed to be the result of similar interoceptive cues to those induced by the training drug.</s></p><p><s>0]<ref type="bibr" target="#b61">[61]</ref><ref type="bibr" target="#b62">[62]</ref><ref type="bibr" target="#b63">[63]</ref><ref type="bibr" target="#b64">[64]</ref> More specifically, assays using selective 5-HT 2A receptor antagonists and intracerebral microinjection of LSD suggest the 5-HT 2A receptor in the anterior cingulate cortex as responsible for the discriminative stimulus properties of LSD in rats (Figure <ref type="figure" target="#fig_0">1</ref>). <ref type="bibr" target="#b65">65</ref></s><s>rug-appropriate responding in the test phase is generally observed when the training and the test drugs are both psychedelic 5-HT 2A receptor agonists. <ref type="bibr" target="#b66">66</ref></s><s>Substitution for LSD in drug discrimination assays does not occur with other psychoactive drugs such as phenyclidine (PCP), <ref type="bibr" target="#b67">67</ref> salvinorin A, <ref type="bibr" target="#b68">68</ref> cocaine, or amphetamine. <ref type="bibr" target="#b69">69</ref></s><s>There are a few false positives such as the nonpsychedelic lisuride, which mimics LSD in traditional two-lever drug discrimination assays.</s><s>However, it has also been shown that lisuride can be discriminated from LSD in three-lever drug discrimination paradigms, <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b59">59,</ref><ref type="bibr" target="#b67">67</ref> suggesting that this paradigm may be able to distinguish between psychedelic and nonpsychedelic 5-HT 2A receptor agonists.</s><s>However, it is still unknown whether a three-lever paradigm discriminates between different psychedelics, and further work is needed to determine whether the three-lever paradigm may be used to categorize psychedelic versus nonpsychedelic 5-HT 2A receptor agonists.</s></p><p><s>Pauses on Fixed-Ratio Schedules of Reinforcement.</s><s>In the fixed-ratio schedule of reinforcement, reinforcements are given only after the animal has emitted a specified number of responses. <ref type="bibr" target="#b70">70</ref></s><s>In a fixed-ratio 40 (FR-40) task, food restricted rats are trained to press a lever 40 times in order to obtain a reward. <ref type="bibr" target="#b70">70</ref></s><s>Two parameters have been used to study the effects of psychedelics in this task: the number of reinforcements obtained, and number of periods of nonresponding lasting 10 s or more (i.e., "pauses").</s><s>2]<ref type="bibr" target="#b73">[73]</ref> Increases in pausing are not observed in animals injected with other psychoactive drugs, such as pentobarbital and amphetamine. <ref type="bibr" target="#b71">71,</ref><ref type="bibr" target="#b74">74</ref></s><s>In addition to reducing the rate of responding, noncompetitive NMDA antagonists have been shown to induce a pause-like effect in monkeys. <ref type="bibr" target="#b75">75</ref></s><s>imilar effects on FR-40 behavior are also induced by the nonpsychedelic 5-HT 2A agonist lisuride in rats. <ref type="bibr" target="#b73">73</ref></s><s>Importantly, the atypical antipsychotic and 5-HT 2A /dopamine D 2 receptor antagonist pipamperone does not affect the effects of lisuride on the number of pauses, but reverses the behavioral effect of psychedelics on FR-40 behavior. <ref type="bibr" target="#b76">76</ref></s><s>Whether pauses on fixedratio schedules of reinforcement in rodents model a behavioral effect induced in humans by psychedelics remains unknown.</s></p><p><s>Locomotor Response and Exploratory Behavior.</s><s>Mark Geyer and his laboratory have extensively studied the effects of psychedelics on locomotion and exploratory behavior in the open field.</s><s>In rats, they found that LSD and DOI induce 5-HT 2A receptor-dependent decreases in the amount of activity (horizontal locomotion), exploratory behavior (number of nose-pokes in a holeboard, and rears), and the tendency to repeatedly follow a similar path (referred to as "path stereotypy" or "spatial scaling exponent d", a paradigm that describes the geometrical properties of movements). <ref type="bibr" target="#b77">77</ref></s><s>When the effects of LSD and lisuride were compared, they found that lisuride induced a biphasic dose-response curve in rats, with suppression and enhancement of horizontal activity at low and high doses, respectively. <ref type="bibr" target="#b78">78</ref></s><s>However, LSD decreased horizontal locomotion, number of nose-pokes, and path stereotypy at all but the lowest dose tested. <ref type="bibr" target="#b78">78</ref></s><s>More recent findings suggest that DOI induces an inverted U-shaped dose-response curve on locomotor activity in mice. <ref type="bibr" target="#b79">79</ref></s><s>Interestingly, the increase in the locomotor activity induced by the lower doses of DOI was absent in 5-HT 2A receptor knockout mice, whereas the reduction in the locomotor activity induced by the higher doses of DOI was reversed by pretreatment with the 5-HT 2C receptor antagonist (+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7-bc][2,6]-naphthyridine (SER-082).</s><s>The authors concluded that 5-HT 2A and 5-HT 2C receptors are responsible for the opposite effects of DOI on the locomotor activity in mice. <ref type="bibr" target="#b79">79</ref></s><s>These findings based on the use of the 5-HT 2A/2C agonist DOI are further supported by the inverted Ushaped dose-response of DOI on head-twitch behavior described above. <ref type="bibr" target="#b47">48</ref></s><s>1]<ref type="bibr" target="#b82">[82]</ref><ref type="bibr" target="#b83">[83]</ref> Recent findings suggest that the 5-HT 2A receptor is involved in the locomotor suppressive effects of clozapine. <ref type="bibr" target="#b84">84,</ref><ref type="bibr" target="#b86">85</ref></s><s>repulse Inhibition of Startle.</s><s>Prepulse inhibition (PPI) of startle is a measure of sensorimotor gating that refers to the reduction in the startle response produced by a low-intensity nonstartling stimulus (the prepulse) presented shortly before the startle stimulus. <ref type="bibr" target="#b87">86</ref></s><s>In humans, psilocybin disrupts PPI at short interstimulus intervals (ISIs), but has no effect at medium ISIs, and, notably, enhances PPI at long ISIs. <ref type="bibr" target="#b88">87,</ref><ref type="bibr" target="#b89">88</ref></s><s>0]<ref type="bibr" target="#b92">[91]</ref> It is also worth noting that, while both lisuride and LSD disrupt PPI in rats, pretreatment with the 5-HT 2A antagonist α-phenyl-1-(2phenylethyl)-4-piperidinemethanol (MDL11939) reverses the effect of LSD, but not that of lisuride.</s><s>The effects of lisuride on PPI are prevented by the dopamine D 2 /D 3 receptor antagonist raclopride. <ref type="bibr" target="#b93">92</ref></s><s>The neuronal circuits through which 5-HT 2Aand/or D 2 /D 3 -dependent signaling affects sensorimotor gating in rodents remain unknown.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACS Chemical Neuroscience</head><p><s>Anxiety-like Behavior.</s><s>The molecular mechanisms responsible for anxiety-like behavior in rodents have been the focus of many studies and models.</s><s>Several studies have reported anxiolytic-like effects of the hallucinogen DOI in conflict-based anxiety tests, with an increase in punisheddrinking behavior and punished-passages in the four-plate test, as well as increased open-arm activity in the elevated plus-maze test. <ref type="bibr" target="#b94">93,</ref><ref type="bibr" target="#b95">94</ref></s><s>Additionally, in rat pups, systemic administration of DOI induces anxiolytic-like behavior, including decreases in ultrasonic vocalizations. <ref type="bibr" target="#b96">95</ref></s><s>These findings contrast with the feelings of fear and anxiety that are frequently precipitated by psychedelics in humans. <ref type="bibr" target="#b97">96</ref></s><s>On the other hand, in rats, DOI induces freezing behavior in the open field exploration test, which suggests that activation of 5-HT 2A receptors by psychedelics affects different measures of anxiety-like behavior differently. <ref type="bibr" target="#b98">97</ref></s><s>ecent findings indicate absence of effect of a low dose of DOI alone on anxiety-like behavior in mice.</s><s>Fergusson and collaborators showed that preadministration of corticotropinreleasing factor (CRF) into the frontal cortex of mice induced 5-HT 2A receptor-dependent anxiety-like behavior in response to the same dose of DOI. <ref type="bibr" target="#b99">98</ref></s><s>They also demonstrated that CRF receptor 1 (CRFR1) affects 5-HT 2A receptor endocytosis and recycling, a mechanism proposed as involved in anxiety-like behavior.</s></p><p><s>That 5-HT 2A receptor-dependent signaling plays a role in anxiety-like behavior is further supported by recent findings in 5-HT 2A receptor knockout mice. <ref type="bibr" target="#b100">99</ref></s><s>These mice show decreased anxiety-like behavior, and rescuing 5-HT 2A receptor expression in cortical neurons normalizes anxiety-like behavior. <ref type="bibr" target="#b100">99</ref></s><s>It has also been suggested that stimulation of 5-HT 2A receptors in the dorsal periaqueductal gray matter induces panicolytic-like behavior in rats. <ref type="bibr" target="#b101">100</ref></s><s>Together, these findings suggest that 5-HT 2A receptors expressed in cortical and midbrain regions exert opposite effects on anxiety-like behavior.</s><s>They also raise the possibility that psychedelics may serve as a research tool to better understand the molecular basis of mood disorders. <ref type="bibr" target="#b21">22</ref></s><s>mpulsivity and Response Inhibition.</s><s>Impulsivity is broadly defined as the inability to withhold a behavioral response when such delay would produce a more favorable outcome.</s><s>It is commonly divided into "impulsive action", which is the inability to withhold a motor response until an appropriate time, and "impulsive choice", which is the selection of a smaller reward more quickly instead of a larger reward that requires a delayed response. <ref type="bibr" target="#b103">101</ref></s><s>Impulsive behaviors are often seen in association with psychiatric disorders, such as schizophrenia, and bipolar disorder. <ref type="bibr" target="#b103">101</ref></s><s>3]<ref type="bibr" target="#b106">[104]</ref> When considering the translational relevance of these preclinical findings, it is important to note that the doses tested were much lower than those used to study head-twitch behavior (see above).</s></p><p><s>Time Perception.</s><s>Time is a fundamental construct for determining the actions we take.</s><s>Time perception has been demonstrated in a variety of species, such as bees, fish, and rodents.</s><s>"Peak interval timing" is one of the behavior models used to investigate time perception in rodents (Figure <ref type="figure" target="#fig_2">2</ref>) <ref type="bibr" target="#b107">105</ref> In this task, test subjects have a choice of responding on either of two levers (A or B) during a trial of a fixed duration (e.g., 50 s).</s><s>In a 50 s trial, pressing on lever A in the first 25 s will result in reward delivery, while, in the second 25 s, only responses on lever B will be rewarded.</s><s>Once the animal has switched from the first lever (A) to the second lever (B), lever A is withdrawn.</s><s>Thus, the maximum number of rewards is obtained by switching from lever A to lever B at exactly 25 s into the trial.</s><s>In short, this task trains animals to indicate with their behavioral response when they perceive a particular duration of time to have passed.</s></p><p><s>Another task to investigate time perception in rodents is "time discrimination", which is a retrospective timing task (Figure <ref type="figure" target="#fig_2">2</ref>).</s><s>In this task, a stimulus, such as light, is presented for a variable duration (t) (e.g., 2.5-50 s).</s><s>During stimulus presentation, no levers are available and no reward can be obtained.</s><s>Following stimulus presentation, there is a timeout period after which the two levers are presented.</s><s>If (t) was less than 25 s, a press on lever A, but not B, is rewarded.</s><s>If (t) was greater than 25 s, lever B, but not A, is rewarded.</s></p><p><s>In a "peak interval timing" task, the psychedelic 5-HT 2A agonist DOI and amphetamine both elicit an overestimate of time intervals in rats, as they tend to press the second lever earlier in time, and, therefore, the curve is shifted to the left. <ref type="bibr" target="#b108">106</ref></s><s>he effects of both DOI and amphetamine on timing performance are reversed by the 5-HT 2A receptor antagonist MDL-100907.</s><s>However, the selective dopamine D 1 receptor antagonist SKF-83566 blocks the effect of amphetamine, but not DOI, on this task. <ref type="bibr" target="#b108">106</ref></s><s>n opposite pattern of errors was observed in the time discrimination task (which is a retrospective timing task), as DOI decreased the percentage of responses on lever B at longer durations. <ref type="bibr" target="#b110">107</ref></s><s>This highlights how similar tasks my produce varying and seemingly contradictory conclusions.</s><s>Using brightness discrimination as a control, it was also found that amphetamine, but not DOI, impaired brightness discrimination.</s><s>Thus, the effects of DOI on time perception may not be attributed to a general deficit in discrimination tasks.</s><s>Clozapine induces similar alterations in peak-interval timing to those observed after injection of DOI or amphetamine. <ref type="bibr" target="#b111">108</ref></s><s>Another interesting finding is that MK-801 (although not ketamine) elicits an opposite effect on peak-interval timing as compared to psychedelic 5-HT 2A agonists. <ref type="bibr" target="#b112">109,</ref><ref type="bibr" target="#b113">110</ref></s><s>he effect of psilocybin on time perception has been studied in humans, and similar results to the peak interval task were found. <ref type="bibr" target="#b114">111</ref></s><s>Volunteers were presented with a test tone of variable duration, followed by a short time-out period, after which a second tone followed.</s><s>Subjects were instructed to press a key to switch off the stimulus when they believed that second tone had been on for the same duration as the previously presented stimulus.</s><s>Although interesting, this paradigm is based on both retrospective judgements of the duration of the stimulus and the timing of the responses, which may confound the different types of judgments made in the "retrospective timing" and "peak interval timing" tasks described in rodents.</s><s>Further investigation is needed regarding the effects of psychoactive 5-HT 2A receptor ligands on time perception in rodents and humans.</s></p><p><s>Memory.</s><s>In some of the few studies in which the effects of psychedelic 5-HT 2A receptor agonists on memory have been investigated, it was reported that LSD and DOI, but not lisuride, enhance trace conditioning of the nictitating membrane response in rabbits (a simple associative learning of a motor response), and this effect was reversed by 5-HT 2A/2C receptor antagonists. <ref type="bibr" target="#b115">112,</ref><ref type="bibr" target="#b116">113</ref></s><s>Fear memory in a trace conditioning paradigm was also affected by activation of the 5-HT 2A receptor in rats, <ref type="bibr" target="#b117">114</ref> as post-training administration of the 5-HT 2A receptor agonist (4-bromo-3,6-dimethoxybenzocyclobuten-1-yl)methylamine hydrobromide (TCB-2) <ref type="bibr" target="#b118">115</ref> enhanced subsequent freezing in a trace fear conditioning test.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>■ CONCLUSION</head><p><s>One of the main limitations in molecular psychiatry is the development of convincing animal models of psychiatric disorders.</s><s>While modeling all the behavioral responses induced by psychedelic drugs is highly unlikely, rodent models recapitulate some individual aspects of the behavioral effects induced by psychedelic drugs in humans.</s><s>The use of pharmacological and genetic tools in rodent models provides compelling evidence that the serotonin 5-HT 2A receptor is the primary target responsible for psychedelic effects.</s><s>Nevertheless, GPCRs such as serotonin 5-HT 2C , dopamine D 2 , dopamine D 1 , glutamate mGlu2, cannabinoid CB 1 , adenosine A 1 , and μopioid, to name a few, have been involved in the modulation (enhancement or attenuation) of 5-HT 2A receptor-dependent cellular signaling pathways and behaviors.</s><s>Further work is necessary to better understand the molecular mechanisms and neuronal circuits through which these receptors modulate the behavioral effects of psychedelics.</s></p><p><s>Rodent behavioral assays, such as head-twitch response, drug discrimination assay, and pauses on fixed-ratio schedules of reinforcement, represent valuable tools to predict psychedelic potential in humans.</s><s>Other behaviors, such as disruption of PPI of startle, changes in locomotor response and exploratory behavior, and alterations in time perception, are affected by various groups of psychoactive drugs, such as psychedelics, dissociatives, and deliriants, and these may be used to obtain a more fine-grained understanding of the similarities and differences between these drugs.</s><s>We look forward to models that will be used for unraveling the neurochemical events that converge on shared patterns of behavioral alterations, or distinguish those that differ.</s></p><p><s>Since studies in healthy volunteers are limited in their ability to probe neurochemical mechanisms, the use of translational animal models will enable to better understand the molecular basis through which psychedelics affect cognition, perception, and mood in humans.</s><s>Elucidating the neuronal and signaling mechanisms underlying psychedelic effects should also help</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACS Chemical Neuroscience</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>■ AUTHOR INFORMATION</head><p><s>Corresponding Author *Mailing address: Department of Psychiatry, Mount Sinai School of Medicine, One Gustave L. Levy Place, New York, NY 10029, USA.</s><s>Phone: 1-212-659-8873.</s><s>Fax: 1-212-996-9785.</s><s>Email: Javier.Maeso@mssm.edu.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Figure 1 .</head><label>1</label><figDesc><div><p><s>Figure 1.</s><s>Neurotransmitter receptor subtypes and neuronal circuits involved in the mechanism of action of psychedelic drugs.</s></p></div></figDesc><graphic coords="2,162.48,280.18,299.96,233.24" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head></head><label></label><figDesc><div><p><s>Review dx.doi.org/10.1021/cn300138m</s><s>| ACS Chem.</s><s>Neurosci.</s><s>2013, 4, 33-42</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Figure 2 .</head><label>2</label><figDesc><div><p><s>Figure 2. Schematic representation of two paradigms of time perception in mice: peak interval timing task and time discrimination task.</s></p></div></figDesc><graphic coords="4,123.19,69.17,378.60,221.39" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head></head><label></label><figDesc><div><p><s>Review dx.doi.org/10.1021/cn300138m</s><s>| ACS Chem.</s><s>Neurosci.</s><s>2013, 4, 33-42 advance our understanding and treatment of endogenous psychoses such as schizophrenia.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Summary of the Effects Hallucinogens in a Range of Behavioral Paradigms</s></p></div></figDesc><table><row><cell></cell><cell>psychedelics (5-HT2A agonists)</cell><cell>dissociatives (NMDA antagonists)</cell><cell>deliriants (muscarinic antagonists)</cell><cell>Salvinorin A (κ-opioid agonist)</cell><cell>amphetamine (DA releaser/ DAT inhibitor) a</cell></row><row><cell>head-twitch</cell><cell>yes 27</cell><cell>unknown</cell><cell>unknown</cell><cell>unknown</cell><cell>unknown</cell></row><row><cell>drug discrimination (LSD-like)</cell><cell>yes 19</cell><cell>no (but potentiates LSD-like effects) 116</cell><cell>unknown</cell><cell>no 68,116</cell><cell>no 116,117</cell></row><row><cell>FR-40 ″pause″</cell><cell>yes 76</cell><cell>yes 75</cell><cell>unknown</cell><cell>unknown</cell><cell>no 118</cell></row><row><cell>locomotion/ exploration</cell><cell>Inverted U-shaped 77,79</cell><cell>increased 119,120</cell><cell>increased 121</cell><cell>decreased 122</cell><cell>yes 123,124</cell></row><row><cell>PPI disruption</cell><cell>yes 89,90,92</cell><cell>yes 125</cell><cell>yes 126</cell><cell>conflicting results 127,128</cell><cell>yes 129,130</cell></row><row><cell>conflict anxiety tests</cell><cell>anxiolytic-like 94,131</cell><cell>anxiolytic-like 132</cell><cell>anxiogenic-like 133</cell><cell>anxiolytic-like 134</cell><cell>conflicting results 135,136</cell></row><row><cell>impulsivity</cell><cell>increased 137,138</cell><cell>increased 139,140</cell><cell>increased 141</cell><cell>unknown</cell><cell>conflicting results 140,142</cell></row><row><cell>peak interval timing</cell><cell>leftward shift 106</cell><cell>rightward shift 109</cell><cell>nonspecific decrease in accuracy 143</cell><cell>unknown</cell><cell>leftward shift 106</cell></row><row><cell>fear conditioning</cell><cell>enhanced 114</cell><cell>impairment 144</cell><cell>impairment 145</cell><cell>unknown</cell><cell>increased at low doses 146</cell></row><row><cell>fear extinction</cell><cell>enhanced 114</cell><cell>impairment under certain conditions 147</cell><cell>impairment 148</cell><cell>unknown</cell><cell>no effect 149</cell></row></table><note><p><s>a DA: dopamine; DAT: dopamine transporter.</s></p></note></figure>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Author Contributions</head><p><s>J.B.H and J.G.-M.</s><s>searched the literature, conceived the topic of the review, and wrote the manuscript.</s></p><p><s>Funding J.G.-M. is supported by a grant from NIH (R01 MH084894).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Notes</head><p><s>The authors declare no competing financial interest.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>■ ACKNOWLEDGMENTS</head><p><s>The authors would like to thank Terrell Holloway and Caitlin McOmish for critical review of the manuscript.</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title level="m" type="main">LSD: My Problem Child</title>
		<author>
			<persName><forename type="first">A</forename><surname>Hofmann</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1980">1980</date>
			<publisher>McGraw-Hill</publisher>
			<pubPlace>New York</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">PIHKAL: Phenethylamines I have known and loved: a chemical love story</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S A</forename><surname>Shulgin</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
			<publisher>Transform Press</publisher>
			<pubPlace>Berkeley</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jesse</forename></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="268" to="283" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Psychological effects of (S)-ketamine and N,N-dimethyltryptamine (DMT): a double-blind, cross-over study in healthy volunteers</title>
		<author>
			<persName><forename type="first">E</forename><surname>Gouzoulis-Mayfrank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Heekeren</surname></persName>
		</author>
		<author>
			<persName><surname>Neukirch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stoll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Stock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Obradovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kovar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacopsychiatry</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="301" to="311" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Psilocybin induces schizophrenialike psychosis in humans via a serotonin-2 agonist action</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Vollenweider-Scherpenhuyzen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Babler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Vogel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">NeuroReport</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3897" to="3902" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">A review of the clinical effects of agents</title>
		<author>
			<persName><forename type="first">H</forename><surname>Osmond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann. N.Y. Acad. Sci</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="418" to="434" />
			<date type="published" when="1957">1957</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Nichols</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hallucinogens. Pharmacol Ther</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="131" to="181" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Agonist-trafficking and hallucinogens</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1017" to="1027" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">PCP: from pharmacology to modelling schizophrenia</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Morris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Cochran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Pratt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="101" to="106" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">NMDA receptors and schizophrenia</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">V</forename><surname>Kristiansen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Huerta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Beneyto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Meador-Woodruff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="48" to="55" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Hallucinogens and dissociative agents naturally growing in the United States</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Halpern</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Ther</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="131" to="138" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Baner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Westkaemper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Siebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Steinberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ernsberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">B</forename><surname>Rothman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="11934" to="11939" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Strassman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R</forename><surname>Qualls</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Uhlenhuth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kellner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch. Gen. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">51</biblScope>
			<biblScope unit="page" from="98" to="108" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Prediction of psilocybin response in healthy volunteers</title>
		<author>
			<persName><forename type="first">E</forename><surname>Studerus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gamma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kometer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">30800</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Psychometric evaluation of the altered states of consciousness rating scale (OAV)</title>
		<author>
			<persName><forename type="first">E</forename><surname>Studerus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gamma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PloS One</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<date type="published" when="2010">2010. 12412</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Hallucinogen actions on 5-HT receptors reveal distinct mechanisms of activation and signaling by G proteincoupled receptors</title>
		<author>
			<persName><forename type="first">H</forename><surname>Weinstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AAPS J</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="871" to="884" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Serotonin receptors</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Nichols</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Nichols</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chem. Rev</title>
		<imprint>
			<biblScope unit="volume">108</biblScope>
			<biblScope unit="page" from="1614" to="1641" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Modeling ″psychosis″ in vitro by inducing disordered neuronal network activity in cortical brain slices</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Aghajanian</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">206</biblScope>
			<biblScope unit="page" from="575" to="585" />
			<date type="published" when="2009">2009</date>
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">LSD, 5-HT (serotonin), and the evolution of a behavioral assay</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Appel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Buggy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Biobehav. Rev</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="693" to="701" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">The behavioral pharmacology of hallucinogens</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Fantegrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Murnane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Reissig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="17" to="33" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Psychoactive drug use in evolutionary perspective</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Nesse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Berridge</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">278</biblScope>
			<biblScope unit="page" from="63" to="66" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">The neurobiology of psychedelic drugs: implications for the treatment of mood disorders</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kometer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat. Rev. Neurosci</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="642" to="651" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Psychedelics and schizophrenia</title>
		<imprint>
			<date type="published" when="2009">2009</date>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="225" to="232" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Serotonin research: contributions to understanding psychoses</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Pharmacol. Sci</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="445" to="453" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">The standardized psychometric assessment of altered states of consciousness (ASCs) in humans</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dittrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacopsychiatry</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="issue">Suppl 2</biblScope>
			<biblScope unit="page" from="80" to="84" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">What&apos;s Wrong With My Mouse?</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Crawley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Behavioral Phenotyping of Transgenic and Knockout Mice</title>
		<imprint>
			<publisher>Wiley, John &amp; Sons</publisher>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Weisstaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Ivic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bradley-Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Ge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Hallucinogens Recruit Specific Cortical 5-HT(2A) Receptor-Mediated Signaling Pathways to Affect Behavior</title>
		<imprint>
			<date type="published" when="2007">2007</date>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="439" to="452" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Transcriptome fingerprints distinguish hallucinogenic and nonhallucinogenic 5-hydroxytryptamine 2A receptor agonist effects in mouse somatosensory cortex</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Ebersole</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Wurmbach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Weisstaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="8836" to="8843" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Tolerance to and Physical Dependence on Morphine in Rats</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">R</forename><surname>Martin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wikler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">G</forename><surname>Eades</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Pescor</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="247" to="260" />
			<date type="published" when="1963">1963</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Production of Abnormal (Psychotic?) Behavior in Mice with Lysergic Acid Diethylamide, and Its Partial Prevention with Cholinergic Drugs and Serotonin</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">W</forename><surname>Woolley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="338" to="344" />
			<date type="published" when="1955">1955</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Permanent alteration of behavior in mice by chemical and psychological means</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Keller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Umbreit</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">124</biblScope>
			<biblScope unit="page" from="723" to="724" />
			<date type="published" when="1956">1956</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">A method for assessing the effects of drugs on the central actions of 5hydroxytryptamine</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Corne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Pickering</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">T</forename><surname>Warner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol. Chemother</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="106" to="120" />
			<date type="published" when="1963">1963</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Screening hallucinogenic drugs: systematic study of three behavioral tests</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Calil</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="163" to="171" />
			<date type="published" when="1975">1975</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The role of central serotonergic mechanisms on head-twitch and backward locomotion induced by hallucinogenic drugs</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ueki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Fantegrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Eckler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Arshad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Coop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Woods</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol., Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="496" to="503" />
			<date type="published" when="1981">1981. 2005</date>
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
	<note>Psychopharmacology</note>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title/>
		<idno type="DOI">.org/10.1021/cn300138m</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Chemical Neuroscience Review dx</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="33" to="42" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>ACS Chem. Neurosci.</note>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Hallucinogen-like effects of N,Ndipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Fantegrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Reissig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">B</forename><surname>Katz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">L</forename><surname>Yarosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="358" to="365" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Cloning of the gene and cDNA for mammalian beta-adrenergic receptor and homology with rhodopsin</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Dixon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Kobilka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Strader</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Benovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">G</forename><surname>Dohlman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Frielle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Bolanowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Rands</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Diehl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">321</biblScope>
			<biblScope unit="page" from="75" to="79" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">The genomic clone G-21 which resembles a beta-adrenergic receptor sequence encodes the 5-HT1A receptor</title>
		<author>
			<persName><forename type="first">A</forename><surname>Fargin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Raymond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Lohse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Kobilka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Caron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Lefkowitz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="page" from="358" to="360" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Structure and functional expression of cloned rat serotonin 5HT-2 receptor</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Pritchett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Bach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wozny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Taleb</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dal Toso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Shih</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Seeburg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">EMBO J</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="4135" to="4140" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Quipazineinduced head-twitch in mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Malick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Doren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Barnett</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="325" to="329" />
			<date type="published" when="1977">1977</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b40">
	<monogr>
		<title level="m" type="main">The central antiserotonergic action of mianserin</title>
		<author>
			<persName><forename type="first">J</forename><surname>Maj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Sowinska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Gancarczyk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Rawlow</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1978">1978</date>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="79" to="84" />
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
	<note type="report_type">Psychopharmacology</note>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Differentiation of 5hydroxytryptamine2 receptor subtypes using 125I-R-(-)2,5-dimethoxy-4-iodo-phenylisopropylamine and 3H-ketanserin</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mckenna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Peroutka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurosci</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="3482" to="3490" />
			<date type="published" when="1989">1989</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">) and [3H] ketanserin label two affinity states of the cloned human 5hydroxytryptamine2 receptor</title>
		<author>
			<persName><forename type="first">T</forename><surname>Branchek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Adham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Macchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">T</forename><surname>Kao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hartig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="604" to="609" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
	<note>3H]-DOB(4-bromo-2,5-dimethoxyphenylisopropylamine</note>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The head-twitch response to intraperitoneal injection of 5-hydroxytryptophan in the rat: antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, an LSD antagonist</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Colpaert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Janssen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="993" to="1000" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Agonistdirected signaling of the serotonin 2A receptor depends on betaarrestin-2 interactions in vivo</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Schmid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Raehal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Bohn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc. Natl. Acad. Sci. U.S.A</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1079" to="1084" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Direct injection of 5-HT2A receptor agonists into the medial prefrontal cortex produces a head-twitch response in rats</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Willins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Meltzer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pharmacol. Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="699" to="706" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Predicting new molecular targets for known drugs</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Keiser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Setola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Irwin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Laggner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">I</forename><surname>Abbas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Hufeisen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">H</forename><surname>Jensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B</forename><surname>Kuijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Matos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">B</forename><surname>Tran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Whaley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Glennon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Thomas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">D</forename><surname>Edwards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Shoichet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">462</biblScope>
			<biblScope unit="page" from="175" to="181" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Fantegrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Simoneau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zimmerman</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice</title>
		<author>
			<persName><forename type="first">M</forename><surname>Henson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Woods</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J .Pharmacol. Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">335</biblScope>
			<biblScope unit="page" from="728" to="734" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">D</forename><surname>Hoyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Clarke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Fozard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hartig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Martin</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen</title>
		<author>
			<persName><forename type="first">R</forename><surname>Mylecharane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Saxena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Humphrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Canal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Olaghere Da Silva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">B</forename><surname>Gresch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Watt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">E</forename><surname>Sanders-Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Airey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="163" to="174" />
			<date type="published" when="1994">1994. 2010</date>
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
	<note>Pharmacol. Rev.</note>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Darmani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Pandya</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neural Transm</title>
		<imprint>
			<biblScope unit="volume">107</biblScope>
			<biblScope unit="page" from="931" to="945" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Darmani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Janoyan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Kumar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Crim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="777" to="787" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">) alpha2-Adrenoceptor antagonists reverse the 5-HT2 receptor antagonist suppression of head-twitch behavior in mice</title>
		<author>
			<persName><forename type="first">K</forename><surname>Matsumoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Mizowaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Thongpraditchote</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Murakami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Watanabe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">56</biblScope>
			<biblScope unit="page" from="417" to="422" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">CB1 knockout mice display impaired functionality of 5-HT1A and 5-HT2A/C receptors</title>
		<author>
			<persName><forename type="first">S</forename><surname>Mato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Aso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Castro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Martín</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Valverde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Maldonado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Pazos</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Neurochem</title>
		<imprint>
			<biblScope unit="volume">103</biblScope>
			<biblScope unit="page" from="2111" to="2120" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Cannabinoids of diverse structure inhibit two DOI-induced 5-HT(2A) receptor-mediated behaviors in mice</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Darmani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="311" to="317" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Holloway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Albizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">493</biblScope>
			<biblScope unit="page" from="76" to="79" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Identification of a serotonin/glutamate receptor complex implicated in psychosis</title>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Ang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yuen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Weisstaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lopez-Gimenez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Okawa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">F</forename><surname>Callado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Milligan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Filizola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Meana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">452</biblScope>
			<biblScope unit="page" from="93" to="97" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Decoding the Signaling of a GPCR Heteromeric Complex Reveals a Unifying Mechanism of Action of Antipsychotic Drugs</title>
		<author>
			<persName><forename type="first">M</forename><surname>Fribourg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Moreno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Holloway</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Provasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Baki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mahajan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Adney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Hatcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Eltit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Ruta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Albizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Umali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fabiato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mackerell</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Brezina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Filizola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Logothetis</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell</title>
		<imprint>
			<biblScope unit="volume">147</biblScope>
			<biblScope unit="page" from="1011" to="1023" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Role of 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. II: Reassessment of LSD false positives</title>
		<author>
			<persName><forename type="first">D</forename><surname>Fiorella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="357" to="363" />
			<date type="published" when="1995">1995</date>
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<monogr>
		<title level="m" type="main">The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of hallucinogenic drugs. I: Antagonist correlation analysis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Fiorella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1995">1995</date>
			<publisher>Psychopharmacology</publisher>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="347" to="356" />
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Serotonergic receptor subtypes and hallucinogen-induced stimulus control</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Fiorella</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Timineri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Filipink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Helsley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="283" to="293" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">The stimulus properties of LSD in C57BL/6 mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Kieres</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Zimmerman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Reissig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Eckler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ullrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Richards</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="830" to="837" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(±)DOI] in C57BL/6J mice</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sanders-Bush</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="61" to="68" />
			<date type="published" when="2003">2003</date>
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Characterization of the discriminative stimulus properties of centrally administered (-)-DOM and LSD</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Doat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Rabin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="713" to="721" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">(serotonin)2A receptors in rat anterior cingulate cortex mediate the discriminative stimulus properties of dlysergic acid diethylamide</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Gresch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Barrett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sanders-Bush</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Smith</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pharmacol. Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="page" from="662" to="669" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">A behavioral and pharmacological analysis of some discriminable properties of d-LSD in rats</title>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">G</forename><surname>Cameron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Appel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="117" to="134" />
			<date type="published" when="1973">1973</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Increasing the selectivity of drug discrimination procedures</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Appel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">B</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">G</forename><surname>Rolandi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Alici</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Pechersky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="353" to="358" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Salvinorin A fails to substitute for the discriminative stimulus effects of LSD or ketamine in Sprague-Dawley rats</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Killinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Peet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Baker</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="260" to="265" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">The effects of 2,5-dimethoxy-4methylamphetamine (DOM), 2,5-dimethoxy-4-ethylamphetamine ACS Chemical Neuroscience Review dx</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Winter</surname></persName>
		</author>
		<idno type="DOI">.org/10.1021/cn300138m</idno>
	</analytic>
	<monogr>
		<title level="m">), d-amphetamine, and cocaine in rats trained with mescaline as a discriminative stimulus</title>
		<imprint>
			<date type="published" when="1975">1975. 2013</date>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="29" to="32" />
		</imprint>
		<respStmt>
			<orgName>DOET</orgName>
		</respStmt>
	</monogr>
	<note>Psychopharmacologia</note>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Mouse behavioral assays relevant to the symptoms of autism</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">N</forename><surname>Crawley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Pathol</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="448" to="459" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">The effects of d-lysergic acid diethylamide (LSD), 2,5-dimethoxy-4-methylamphetamine (DOM) and d-amphetamine on operant responding in control and 6-hydroxydopamine-treated rats</title>
		<author>
			<persName><forename type="first">R</forename><surname>Commissaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Lyness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Cordon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="621" to="626" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Enhancement of the behavioral effects of 2,5-dimethoxy-4methyl-amphetamine (DOM) by pretreatment with p-chlorophenylalanine</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Commissaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Lyness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="605" to="608" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Behavioral effects of intracerebroventricular administration of LSD, DOM, mescaline or lisuride</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mokler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol., Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="281" to="287" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Central 5-hydroxytryptamine and the effects of hallucinogens and phenobarbital on operant responding in rats</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Commissaris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Lyness</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page" from="595" to="601" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Effects of phencyclidine, ketamine and MDMA on complex operant behavior in monkeys</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Thompson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Winsauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mastropaolo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page" from="401" to="405" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">The 5HT2 antagonist pirenperone reverses disruption of FR-40 by hallucinogenic drugs</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Mokler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">W</forename><surname>Stoudt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="677" to="682" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Effects of hallucinogens on locomotor and investigatory activity and patterns: influence of 5-HT2A and 5-HT2C receptors</title>
		<author>
			<persName><forename type="first">K</forename><surname>Krebs-Thomson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Paulus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="339" to="351" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Patterns of exploration in rats distinguish lisuride from lysergic acid diethylamide</title>
		<author>
			<persName><forename type="first">L</forename><surname>Adams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="461" to="468" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b79">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Halberstadt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Van Der Heijden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ruderman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">B</forename><surname>Risbrough</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Powell</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">HT(2A) and 5-HT(2C) receptors exert opposing effects on locomotor activity in mice</title>
		<author>
			<persName><forename type="first">I</forename><surname>Ninan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Kulkarni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="111" to="116" />
			<date type="published" when="1958">1958-1967. (80. 1998</date>
		</imprint>
	</monogr>
	<note>Eur. J. Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">5-HT2 receptor antagonism reduces hyperactivity induced by amphetamine, cocaine, and MK-801 but not D1 agonist C-APB</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>O'neill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Heron-Maxwell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Shaw</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="237" to="243" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b82">
	<analytic>
		<title level="a" type="main">The role of serotonin receptors in the action of atypical antipsychotic drugs</title>
		<author>
			<persName><forename type="first">H</forename><surname>Meltzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Massey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr. Opin. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="59" to="67" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<analytic>
		<title level="a" type="main">Serotonergic involvement in methamphetamine-induced locomotor activity: a detailed pharmacological study</title>
		<author>
			<persName><forename type="first">E</forename><surname>Steed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Jones</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Mccreary</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">220</biblScope>
			<biblScope unit="page" from="9" to="19" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Ingram</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Levine</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Resnik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Kamel</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Reduced Levels of Serotonin 2A Receptors Underlie Resistance of Egr3-Deficient Mice to Locomotor Suppression by Clozapine</title>
		<author>
			<persName><forename type="first">M</forename><surname>Lish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Elizalde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">I</forename><surname>Janowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Shoker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kozlenkov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gallitano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology X</title>
		<imprint>
			<biblScope unit="volume">XXXX</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Clozapine-Induced Locomotor Suppression is Mediated by 5-HT(2A) Receptors in the Forebrain</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Mcomish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Hanks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology X</title>
		<imprint>
			<biblScope unit="volume">XXXX</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Overview of animal models of schizophrenia</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">B</forename><surname>Powell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Current Protocols in Neuroscience</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page">24</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">The effects of the preferential 5-HT2A agonist psilocybin on prepulse inhibition of startle in healthy human volunteers depend on interstimulus interval</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Csomor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Knappe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Quednow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1876" to="1887" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Effect of LSD on prepulse inhibition and spontaneous behavior in the rat. A pharmacological analysis and comparison between two rat strains</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ouagazzal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Grottick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Moreau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Higgins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="565" to="575" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">DOI-induced deficits in prepulse inhibition in Wistar rats are reversed by mGlu2/3 receptor stimulation</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wischhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">E A</forename><surname>Aho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacology</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="6" to="12" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Regulation of sensorimotor gating of the startle reflex by serotonin 2A receptors. Ontogeny and strain differences</title>
		<author>
			<persName><forename type="first">M</forename><surname>Farid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">A</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Swerdlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="623" to="632" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Pharmacological and parametrical investigation of prepulse inhibition of startle and prepulse elicited reactions in Wistar rats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Brosda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Hayn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Klein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schallhorn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wegener</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="22" to="28" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">LSD but not lisuride disrupts prepulse inhibition in rats by activating the 5-HT(2A) receptor</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Halberstadt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">208</biblScope>
			<biblScope unit="page" from="179" to="189" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">The role of 5-HT receptor subtypes in the anxiolytic effects of selective serotonin reuptake inhibitors in the rat ultrasonic vocalization test</title>
		<author>
			<persName><forename type="first">R</forename><surname>Schreiber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Melon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>De Vry</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">135</biblScope>
			<biblScope unit="page" from="383" to="391" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Nic Dhonnchadha</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bourin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hascoeẗ</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">140</biblScope>
			<biblScope unit="page" from="203" to="214" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Serotonergic modulation of the rat pup ultrasonic isolation call: studies with 5HT1 and 5HT2 subtype-selective agonists and antagonists</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Winslow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Insel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="513" to="520" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title level="a" type="main">Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">R</forename><surname>Griffiths</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">W</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">A</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Mccann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jesse</forename></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">218</biblScope>
			<biblScope unit="page" from="649" to="665" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<analytic>
		<title level="a" type="main">Behavioral responses to stress following central and peripheral injection of the 5-HT(2) agonist DOI</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Hawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Uzelac</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Baumeister</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Hearn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Broussard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Guillot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="537" to="544" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">CRF receptor 1 regulates anxiety behavior via sensitization of 5-HT2 receptor signaling</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Magalhaes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Holmes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">B</forename><surname>Dale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Comps-Agrar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">N</forename><surname>Yadav</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Drysdale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">O</forename><surname>Poulter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-P</forename><surname>Pin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Anisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S G</forename><surname>Ferguson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature Neurosci</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="622" to="629" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">Cortical 5-HT2A receptor signaling modulates anxiety-like behaviors in mice</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">V</forename><surname>Weisstaub</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Lambe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gonzalez-Maeso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Hornung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Sibille</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Underwood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Itohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">T</forename><surname>Dauer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Ansorge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Morelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Mann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Toth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Aghajanian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Sealfon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Hen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Gingrich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Science</title>
		<imprint>
			<biblScope unit="volume">313</biblScope>
			<biblScope unit="page" from="536" to="540" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Sergio</forename><surname>De Oliveira</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>De Bortoli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Zangrossi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jr</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Serotonin-2A receptor regulation of panic-like behavior in the rat dorsal periaqueductal gray matter: the role of GABA</title>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">218</biblScope>
			<biblScope unit="page" from="725" to="732" />
			<pubPlace>Berlin, Ger</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">The utility of rat models of impulsivity in developing pharmacotherapies for impulse control disorders</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Winstanley</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">164</biblScope>
			<biblScope unit="page" from="1301" to="1321" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Effects of acute intracerebral administration of the 5-HT(2A/C) receptor ligands DOI and ketanserin on impulse control in rats</title>
		<author>
			<persName><forename type="first">M</forename><surname>Hadamitzky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="88" to="92" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Impulsive behaviour in rats induced by intracortical DOI infusions is antagonized by co-administration of an mGlu2/3 receptor agonist</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wischhof</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Hollensteiner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Koch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="805" to="813" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task</title>
		<author>
			<persName><forename type="first">T</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ruotsalainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Puumala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lappalainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Koivisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Mannisto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sirvio</surname></persName>
		</author>
		<idno type="DOI">.org/10.1021/cn300138m|ACSChem.Neurosci.2013</idno>
	</analytic>
	<monogr>
		<title level="j">ACS Chemical Neuroscience Review dx</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="33" to="42" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>Neuropharmacology</note>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Cortico-striatal circuits and interval timing: coincidence detection of oscillatory processes</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Matell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Meck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain research. Cognitive Brain Res</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="139" to="170" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">S</forename><surname>Body</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H C</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bezzina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Asgari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Fone</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<author>
			<persName><forename type="first">F</forename><surname>Glennon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Bradshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Szabadi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Effects of d-amphetamine and DOI (2,5-dimethoxy-4-iodoamphetamine) on timing behavior: interaction between D1 and 5-HT2A receptors</title>
		<imprint>
			<date type="published" when="2006">2006</date>
			<biblScope unit="volume">189</biblScope>
			<biblScope unit="page" from="331" to="343" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Comparison of the effects of 2,5-dimethoxy-4iodoamphetamine and D-amphetamine on the ability of rats to discriminate the durations and intensities of light stimuli</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Hampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Body</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Den Boon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H C</forename><surname>Cheung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bezzina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Langley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C F</forename><surname>Fone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bradshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Szabadi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="11" to="20" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Differential effects of clozapine and haloperidol on interval timing in the supraseconds range</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Meck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">182</biblScope>
			<biblScope unit="page" from="232" to="244" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Effects of the NMDA receptor antagonist MK-801 on short-interval timing in rats</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Mcauley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C H</forename><surname>Pang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Neurosci</title>
		<imprint>
			<biblScope unit="volume">120</biblScope>
			<biblScope unit="page" from="162" to="172" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Differential effects of cocaine and ketamine on time estimation: implications for neurobiological models of interval timing</title>
		<author>
			<persName><forename type="first">R.-K</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Macdonald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Meck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="114" to="122" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Effects of psilocybin on time perception and temporal control of behaviour in humans</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wittmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Carter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Hasler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">R</forename><surname>Cahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Grimberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Spring</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Hell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Flohr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">X</forename><surname>Vollenweider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Psychopharmacol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="50" to="64" />
			<date type="published" when="2007">2007</date>
			<pubPlace>Oxford, U.K.</pubPlace>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Serotonergic regulation of associative learning</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harvey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">73</biblScope>
			<biblScope unit="page" from="47" to="50" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Effects of serotonin 5-HT(2A/2C) antagonists on associative learning in the rabbit</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Welsh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Romano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harvey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">137</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Stimulation of serotonin 2A receptors facilitates consolidation and extinction of fear memory in C57BL/6J mice</title>
		<author>
			<persName><forename type="first">G</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">N</forename><surname>Asgeirsdottir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Cohen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">H</forename><surname>Munchow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Barrera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">W</forename><surname>Stackman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">1-Aminomethylbenzocycloalkanes: conformationally restricted hallucinogenic phenethylamine analogues as functionally selective 5-HT2A receptor agonists</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Mclean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Parrish</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Braden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Marona-Lewicka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gallardo-Godoy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">E</forename><surname>Nichols</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Med. Chem</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="5794" to="5803" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Discriminative stimulus effects of 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane in rhesus monkeys</title>
		<author>
			<persName><forename type="first">J.-X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>Rice</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">P</forename><surname>France</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pharmacol. Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">324</biblScope>
			<biblScope unit="page" from="827" to="833" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">The role of dopamine and serotonin in the discriminative stimulus effects of lisuride</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>White</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Appel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pharmacol Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">221</biblScope>
			<biblScope unit="page" from="421" to="427" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Neurotransmitter basis of the behavioral effects of hallucinogens</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Rech</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Commissaris</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Biobehav. Rev</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="521" to="527" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">The dopamine D3 receptor mediates locomotor hyperactivity induced by NMDA receptor blockade</title>
		<author>
			<persName><forename type="first">L</forename><surname>Leriche</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J.-C</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Sokoloff</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="174" to="181" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">The supramammillo-septalhippocampal pathway mediates sensorimotor gating impairment and hyperlocomotion induced by MK-801 and ketamine in rats</title>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">S</forename><surname>Leung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">191</biblScope>
			<biblScope unit="page" from="961" to="974" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Repeated ketamine administration produces upregulation of muscarinic acetylcholine receptors in the forebrain, and reduces behavioral sensitivity to scopolamine in mice</title>
		<author>
			<persName><forename type="first">T</forename><surname>Morita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Hitomi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Uchihashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kuribara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">117</biblScope>
			<biblScope unit="page" from="396" to="402" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Multi-dimensional analyses of behavior in mice treated with U-50,488H, a purported kappa (non-mu) opioid agonist</title>
		<author>
			<persName><forename type="first">M</forename><surname>Ukai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kameyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res</title>
		<imprint>
			<biblScope unit="volume">337</biblScope>
			<biblScope unit="page" from="352" to="356" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">) alpha 1d Adrenoceptor signaling is required for stimulus induced locomotor activity</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sadalge</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Coughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Fu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Valladares</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Valentino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Blendy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page" from="664" to="672" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Strain differences in lithium attenuation of d-amphetamineinduced hyperlocomotion: a mouse model for the genetics of clinical response to lithium</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Gould</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">C</forename><surname>O'donnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Picchini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Manji</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="1321" to="1333" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">M100907, a serotonin 5-HT2A receptor antagonist and putative antipsychotic, blocks dizocilpine-induced prepulse inhibition deficits in Sprague-Dawley and Wistar rats</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">B</forename><surname>Varty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">P</forename><surname>Bakshi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Geyer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="311" to="321" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Reversal of scopolamineinduced disruption of prepulse inhibition by clozapine in mice</title>
		<author>
			<persName><forename type="first">P</forename><surname>Singer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Yee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol., Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">101</biblScope>
			<biblScope unit="page" from="107" to="114" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Kappa opioid receptor activation disrupts prepulse inhibition of the acoustic startle in rats</title>
		<author>
			<persName><forename type="first">M</forename><surname>Bortolato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">N</forename><surname>Aru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Frau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Orru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Manunta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Puddu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Mereu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Gessa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1550" to="1558" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Tejeda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">I</forename><surname>Chefer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zapata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Shippenberg</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">The effects of kappa-opioid receptor ligands on prepulse inhibition and CRF-induced prepulse inhibition deficits in the rat</title>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">210</biblScope>
			<biblScope unit="page" from="231" to="240" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Metabotropic glutamate subtype 5 receptors modulate locomotor activity and sensorimotor gating in rodents</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Kinney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Burno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">C</forename><surname>Campbell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Hernandez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Rodriguez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">J</forename><surname>Bristow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Conn</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Pharmacol. Exp. Ther</title>
		<imprint>
			<biblScope unit="volume">306</biblScope>
			<biblScope unit="page" from="116" to="123" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Amphetamine effects on prepulse inhibition across-species: replication and parametric extension</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Swerdlow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Stephany</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Wasserman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Talledo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Shoemaker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Auerbach</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="640" to="650" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Implication of the 5-HT2A and 5-HT2C (but not 5HT1A) receptors located within the periaqueductal gray in the elevated plus-maze test-retest paradigm in mice</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Gomes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Nunes-De-Souza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog. Neuro-Psychopharmacol. Biol. Psychiatry</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="1261" to="1269" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Effects of cholinergic system of dorsal hippocampus of rats on MK-801 induced anxiolytic-like behavior</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Zarrindast</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nasehi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Piri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Heidari</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">505</biblScope>
			<biblScope unit="page" from="65" to="70" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">Effects of scopolamine and its quaternary analogue in the murine elevated plus-maze test of anxiety</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Rodgers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Cole</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="283" to="289" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title level="a" type="main">Potential anxiolytic-and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents</title>
		<author>
			<persName><forename type="first">D</forename><surname>Braida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Capurro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Zani</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Rubino</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vigano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Parolaro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sala</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br. J. Pharmacol</title>
		<imprint>
			<biblScope unit="volume">157</biblScope>
			<biblScope unit="page" from="844" to="853" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Amphetamine-induced anxietyrelated behavior in animal models</title>
		<author>
			<persName><forename type="first">G</forename><surname>Biała</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kruk</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacol. Rep</title>
		<imprint>
			<biblScope unit="volume">59</biblScope>
			<biblScope unit="page" from="636" to="644" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Utility of ethological analysis to overcome locomotor confounds in elevated maze models of anxiety</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Weiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wadsworth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">T</forename><surname>Dourish</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Biobehav. Rev</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="265" to="271" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Studies on the involvement of the dopaminergic system in the 5-HT2 agonist (DOI)-induced premature responding in a five-choice serial reaction time task</title>
		<author>
			<persName><forename type="first">T</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sirvio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Brain Res. Bull</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="65" to="75" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">The 5-HT(2) receptor activation enhances impulsive responding without increasing motor activity in rats</title>
		<author>
			<persName><forename type="first">T</forename><surname>Koskinen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ruotsalainen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sirvio</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem. Behav</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="729" to="738" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
	<note>Pharmacol.</note>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">The 5-HT2A receptor antagonist M100,907 attenuates motor and &apos;impulsive-type&apos; behaviours produced by NMDA receptor antagonism</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">A</forename><surname>Higgins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Enderlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Haman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">170</biblScope>
			<biblScope unit="page" from="309" to="319" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title level="a" type="main">Impulsive action induced by amphetamine, cocaine and MK801 is reduced by 5-HT(2C) receptor stimulation and 5-HT(2A) receptor blockade</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Fletcher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Rizos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Noble</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Higgins</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropharmacology</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="468" to="477" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Effects of acute administration of nicotinic and muscarinic cholinergic agonists and antagonists on performance in different cost-benefit decision making tasks in rats</title>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">A</forename><surname>Mendez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Gilbert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Bizon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Setlow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">Opposite effects of amphetamine on impulsive action with fixed and variable delays to respond</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Hayton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Maracle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Olmstead</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="651" to="659" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Pharmacological manipulations of interval timing using the peak procedure in male C3H mice</title>
		<author>
			<persName><forename type="first">F</forename><surname>Balci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Ludvig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Frank</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Kapustinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Fedolak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Brunner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacologia</title>
		<imprint>
			<biblScope unit="volume">201</biblScope>
			<biblScope unit="page" from="67" to="80" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Deficits in emotional learning and memory in an animal model of schizophrenia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Bolton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">F</forename><surname>Heaney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Sabbagh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Murtishaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Magcalas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Kinney</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Brain Res</title>
		<imprint>
			<biblScope unit="volume">233</biblScope>
			<biblScope unit="page" from="35" to="44" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Scopolamine administered before and after training impairs both contextual and auditory-cue fear conditioning</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Rudy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurobiol. Learn. Mem</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="73" to="81" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Memory and psychostimulants: modulation of Pavlovian fear conditioning by amphetamine in C57BL/6 mice</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Anagnostaras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Psychopharmacology</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="197" to="206" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Conditioned stimulus familiarity determines effects of MK-801 on fear extinction</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">Y M</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">P</forename><surname>Mcnally</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Behav. Neurosci</title>
		<imprint>
			<biblScope unit="volume">123</biblScope>
			<biblScope unit="page" from="303" to="314" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Muscarinic receptors modulate the intrinsic excitability of infralimbic neurons and consolidation of fear extinction</title>
		<author>
			<persName><forename type="first">E</forename><surname>Santini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Sepulveda-Orengo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Porter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuropsychopharmacology</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="2047" to="2056" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Amphetamine and extinction of cued fear</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Carmack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Anagnostaras</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neurosci. Lett</title>
		<imprint>
			<biblScope unit="volume">468</biblScope>
			<biblScope unit="page" from="18" to="22" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
